A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

If you’re under age 12, we don’t have any drug that is specifically indicated,” Dr. Lawrence F. Eichenfield said.

Ritlecitinib is under clinical development by Pfizer and currently in Phase II for Keloids. According to GlobalData, Phase II drugs for Keloids does not have sufficient historical data to build an ...

Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I-43124 Parma, Italy ...

Department of Dermatology, Institute of Regenerative Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, China Vitiligo is an autoimmune disease characterized by the loss of functional ...

WEDNESDAY, Jan. 8, 2025 (HealthDay News) -- For patients with nonsegmental vitiligo, ritlecitinib alone and with add-on narrow-band ultraviolet B (nbUVB) phototherapy improves facial and total body ...

The first image shows a patient prior to treatment with ritlecitinib. The second image shows complete hair regrowth while taking ritlecitinib. Credit: Yale University Alopecia areata is characterized ...